Eris Lifesciences Limited (BOM:540596)
India flag India · Delayed Price · Currency is INR
1,414.65
-96.40 (-6.38%)
At close: Feb 13, 2026

Eris Lifesciences Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Market Capitalization
195,927192,990114,71977,80193,61582,147
Market Cap Growth
24.82%68.23%47.45%-16.89%13.96%64.00%
Enterprise Value
223,191221,970121,26880,08592,60080,183
Last Close Price
1414.651416.50836.45568.82677.98589.96
PE Ratio
45.4654.8529.2620.3623.0523.13
PS Ratio
6.396.705.764.687.066.89
PB Ratio
5.595.903.563.504.915.21
P/TBV Ratio
----8.1010.28
P/FCF Ratio
-21.2132.15-36.3923.50
P/OCF Ratio
-18.1223.6026.6724.7521.89
EV/Sales Ratio
7.287.716.094.826.986.72
EV/EBITDA Ratio
18.2122.0918.3015.2319.1818.82
EV/EBIT Ratio
27.4631.5924.5318.9921.8120.69
EV/FCF Ratio
-24.3933.98-36.0022.94
Debt / Equity Ratio
0.680.760.860.400.050.01
Debt / EBITDA Ratio
2.242.444.131.660.190.04
Debt / FCF Ratio
3.952.727.79-0.360.05
Net Debt / Equity Ratio
0.660.700.450.36-0.06-0.07
Net Debt / EBITDA Ratio
2.192.262.181.53-0.25-0.26
Net Debt / FCF Ratio
3.832.504.04-1.47-0.46-0.32
Asset Turnover
0.420.410.370.560.650.70
Inventory Turnover
2.272.802.472.902.492.95
Quick Ratio
0.470.560.751.221.991.78
Current Ratio
0.910.890.911.733.142.80
Return on Equity (ROE)
13.42%11.54%14.59%18.12%23.29%24.72%
Return on Assets (ROA)
6.78%6.24%5.77%8.87%12.92%14.31%
Return on Invested Capital (ROIC)
10.51%10.55%11.84%16.19%23.95%26.52%
Return on Capital Employed (ROCE)
13.70%12.40%11.00%13.10%20.50%23.20%
Earnings Yield
2.20%1.82%3.42%4.91%4.34%4.32%
FCF Yield
-4.71%3.11%-7.07%2.75%4.26%
Dividend Yield
-0.52%-1.29%0.89%0.93%
Payout Ratio
-28.44%-26.14%20.10%21.03%
Buyback Yield / Dilution
-0.01%-0.09%-0.03%-0.19%-0.02%1.03%
Total Shareholder Return
-0.01%0.43%-0.03%1.10%0.86%1.97%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.